{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:58:54Z","timestamp":1779249534762,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1992,9,1]],"date-time":"1992-09-01T00:00:00Z","timestamp":715305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1992,9]]},"DOI":"10.1007\/bf00399937","type":"journal-article","created":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T08:04:32Z","timestamp":1098345872000},"page":"884-888","source":"Crossref","is-referenced-by-count":24,"title":["Cyclosporin A treatment of young children with newly-diagnosed Type 1 (insulin-dependent) diabetes mellitus"],"prefix":"10.1007","volume":"35","author":[{"given":"M.","family":"Jenner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bradish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Atkison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The London Diabetes Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(86)91943-4","volume":"II","author":"G Feutren","year":"1986","unstructured":"Feutren G, Papoz L, Assan R, Vialettes et al. (1986) Cyclosporin increases the rate and length of remission in insulin-dependent diabetes of recent onset. Lancet II: 119?124","journal-title":"Lancet"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/diab.37.11.1574","volume":"37","author":"Canadian-European randomized control trial group","year":"1988","unstructured":"Canadian-European randomized control trial group (1988) Cyclosporine-induced remission of IDDM after early intervention. Association of one year of cyclosporine with enhanced insulin secretion. Diabetes 37: 1574?1582","journal-title":"Diabetes"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0022-3476(87)80058-6","volume":"111","author":"CR Stiller","year":"1987","unstructured":"Stiller CR, Dupr\u00e9 J, Gent M et al. (1987) Effects of cyclosporine in recent-onset juvenile Type 1 diabetes: impact of age and duration of disease. J Pediatr 111: 1069?1072","journal-title":"J Pediatr"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198803173181103","volume":"38","author":"PF Bougneres","year":"1988","unstructured":"Bougneres PF, Carel JC, Castano L et al. (1988) Factors determining early remission of Type 1 diabetes in children treated with cyclosporin A. N Engl J Med 38: 663?670","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0022-3476(87)80059-8","volume":"111","author":"JF Bach","year":"1987","unstructured":"Bach JF (1987) Cyclosporine in insulin-dependent diabetes mellitus. J Pediatr 111: 1073?1074","journal-title":"J Pediatr"},{"key":"CR6","first-page":"356","volume":"20","author":"G Feutren","year":"1988","unstructured":"Feutren G (1988) Functional consequences and risk factors of chronic cyclosporin A nephrotoxicity in Type 1 diabetes trials. Transplant Proc 20: 356?366","journal-title":"Transplant Proc"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.6367043","volume":"223","author":"CR Stiller","year":"1984","unstructured":"Stiller CR, Dupr\u00e9 J, Gent M et al. (1984) Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223: 1362?1367","journal-title":"Science"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(83)91558-1","volume":"I","author":"A Laupacis","year":"1983","unstructured":"Laupacis A, Stiller CR, Gardell C et al. (1983) Cyclosporin prevents diabetes in BB Wistar rats. Lancet I: 10?12","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(85)91964-6","volume":"I","author":"R Assan","year":"1985","unstructured":"Assan R, Sachs MD, Laborie C et al. (1985) Metabolic and immunologic effect of cyclosporine in recently diagnosed Type 1 diabetes mellitus. Lancet I: 67?71","journal-title":"Lancet"},{"key":"CR10","first-page":"184","volume":"20","author":"J Dupr\u00e9","year":"1988","unstructured":"Dupr\u00e9 J, Stiller CR, Gent M et al. (1988) Effects of immunosuppression with cyclosporine in insulin dependent diabetes mellitus of recent onset: the Canadian open study of 44 months. Transplant Proc 20: 184?192","journal-title":"Transplant Proc"},{"key":"CR11","first-page":"11","volume-title":"Progress in transplantation","author":"CR Stiller","year":"1984","unstructured":"Stiller CR, Keown PA (1984) Cyclosporine therapy in perspective: In Morris PJ, Tilney NL (eds) Progress in transplantation. Churchill Livingstone, Edinburgh, pp 11?45"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2337\/diab.39.10.1264","volume":"39","author":"PF Bougn\u00e8res","year":"1990","unstructured":"Bougn\u00e8res PF, Landais P, Boisson C et al. (1990) Limited duration of remission of insulin dependency in children with recent overt type 1 diabetes treated with low-dose cyclosporin. Diabetes 39: 1264?1272","journal-title":"Diabetes"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"A208","DOI":"10.1007\/BF00404798","volume":"33","author":"D Finegood","year":"1990","unstructured":"Finegood D, Hramiak IM, Dupr\u00e9 J (1990) Relationship between stimulated C-peptide responses and insulin sensitivity in insulin-dependent diabetics treated with cyclosporin. Diabetologia 33 [Suppl]: A208 (Abstract)","journal-title":"Diabetologia"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0896-8411(88)90062-5","volume":"1","author":"JF Bach","year":"1988","unstructured":"Bach JF (1988) The risk\/benefit ratio in immunointervention for autoimmune diseases. J Autoimmun 1: 711?720","journal-title":"J Autoimmun"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/0896-8411(92)90014-H","volume":"5","author":"JF Bach","year":"1992","unstructured":"Bach JF (1992) Immunointervention in autoimmune diseases from cellular selectivity to autoantigen specificity. J Autoimmun 5 [Suppl]: A3?10","journal-title":"J Autoimmun"},{"key":"CR16","unstructured":"Editorial (1984) Lymphoma in organ transplant recipients. Lancet I: 601?603"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00007890-198505000-00001","volume":"39","author":"DW Hanto","year":"1985","unstructured":"Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL (1985) Epstein-Barr virus, immunodeficiency and B cell lymphoproliferation. Transplantation 39: 461?472","journal-title":"Transplantation"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00007890-198804000-00011","volume":"45","author":"M Ho","year":"1988","unstructured":"Ho M, Jaffe R, Miller G et al. (1988) The frequency of EpsteinBarr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45: 719?727","journal-title":"Transplantation"},{"key":"CR19","first-page":"1011","volume":"23","author":"RB Ettenger","year":"1991","unstructured":"Ettenger RB, Rosenthal JT, Marik J et al. (1991) Long-term results with cyclosporine immune suppression in pediatric cadaver renal transplantation. Transplant Proc 23: 1011?1012","journal-title":"Transplant Proc"},{"key":"CR20","first-page":"1013","volume":"23","author":"B Klore","year":"1991","unstructured":"Klore B, Strom TM, Hahn H et al. (1991) Remarkable long-term prognosis and excellent growth in kidney-transplant children under cyclosporine monotherapy. Transplant Proc 23: 1013?1017","journal-title":"Transplant Proc"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF00405010","volume":"34","author":"RB Elliott","year":"1991","unstructured":"Elliott RB, Chase HP (1991) Prevention of delay of Type 1 (insulin dependent) diabetes mellitus in children using nicotinamide. Diabetologia 34: 362?365","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00399937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00399937\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00399937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T22:30:41Z","timestamp":1554330641000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00399937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1992,9]]}},"alternative-id":["BF00399937"],"URL":"https:\/\/doi.org\/10.1007\/bf00399937","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,9]]}}}